Oonagh Sheehy
Belfast, NIR, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Belantamab mafodotin-associated keratopathy: Clinical outcomes and management from two UK tertiary centres.
Journal: British journal of haematology
Published: February 20, 2026
Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.
Journal: The New England journal of medicine
Published: June 16, 2025
The PI3Kδ inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 study.
Journal: HemaSphere
Published: February 06, 2024
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
Journal: The New England journal of medicine
Published: December 11, 2023
Real-world efficacy of single-agent belantamab mafodotin in relapsed systemic AL amyloidosis.
Journal: British journal of haematology
Published: October 15, 2023
Neurology and the histiocytoses: a case of Rosai-Dorfman-Destombes disease.
Journal: Practical neurology
Published: April 03, 2022
Pituitary metastasis: a clinical overview.
Journal: The Ulster medical journal
Published: November 24, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026